News — Capra Biosciences

Capra Biosciences May 19, 2026

Product launch · Personal care

Capra launches bioproduced salicylic acid for personal care at NYSCC Suppliers' Day.

Made with Capra's biomanufacturing technology, our salicylic acid offers formulators a high-purity, 100% plant-based and U.S.-made alternative to conventional supply.

Read announcement → See all coverage

In the press.

Recent highlights.

Capra launches bioproduced salicylic acid for personal care at NYSCC Suppliers' Day.

Could 'Chickpea-Sized' Biosensors Make Biomanufacturing More Cost Competitive?

Capra Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers' Day

BioMADE Announces $21.4M Invested in 14 Projects to Develop the U.S. Bioindustrial Manufacturing Industry

U.S. Manufacturing Unprepared for BIOSECURE Act's Repercussions

Capra Biosciences Joins BioMAP Consortium to Scale Pharmaceutical Manufacturing

Capra Lands $7.5M Project Agreement to Demonstrate Platform for Rapidly Scaling Pharmaceutical Ingredient Manufacturing

Capra Biosciences Wins $7.5M Award to Scale and Manufacture Bio-Derived Small-Molecule APIs

CoMPASS: Continuous Biomanufacturing Process Analysis for Scaling API Synthesis

How Microbes Are Changing Manufacturing — Why We Invested in Capra Biosciences

Harnessing Biofilms for Biomanufacturing and as Living Materials

Reimagining the Bioreactor

Capra Biosciences Raises $1.8M in Pre-Seed Round for Renewable Chemical Innovations

Capra Biosciences Pulls in Funding for Novel Bioreactor Tech

Working on a story about Capra?